Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Clinical trial NCT02422797 · COMPLETED
Trial details
- NCT number
- NCT02422797
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-21
- Primary completion
- 2016-09-16
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.